跳至主要内容
临床试验/NCT04554004
NCT04554004已完成不适用

A Clinical Trial for CT Myocardial Perfusion Based Non-invasive Index of Microciculatory Resistance

First People's Hospital of Hangzhou1 个研究点 分布在 1 个国家目标入组 295 人开始时间: 2022年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
295
试验地点
1
主要终点
sensitivity and specificity

研究概览

简要总结

Coronary artery microvascular disease (CMVD) lacks reliable and non-invasive quantitative diagnosis methods. Improving coronary microcirculation has become one of the main goals of coronary heart disease treatment. In this study, by establishing the key influencing factors of myocardial microcirculation perfusion, an accurate three-dimensional reconstruction method of coronary artery was established, and a non-invasive coronary microcirculation resistance index (CT-IMR) calculation method based on computational fluid method mechanics was established. At the same time, a phase I single-center clinical verification and a multi-center clinical verification of the non-invasive coronary microcirculation function precision assessment system were carried out, and a non-invasive coronary microcirculation detection system and technology were established.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subject must be older than 18 years
  • •Written informed consent available
  • •Subject is indicated for invasive coronary angiography
  • •Subject need to be taken within 30 days after enrolment

排除标准

  • •Previous PCI or CABG
  • •Subject is not eligible for measuring IMR
  • •Complicated complex congenital heart disease
  • •Artificial pacemaker or internal defibrillator leads implanted
  • •Implanted artificial heart valve
  • •Severe arrhythmia including complete AV block, ventricular arrhythmia
  • •Impaired chronic renal function (serum creatinine>1.5ULN)
  • •Allergic to iodine
  • •Pregnancy
  • •Body mass index >35 kg/m2
  • •Left ventricle is markedly thickened
  • •Needs for emergency procedures
  • •Severe distortion of in the blood vessel
  • •Unstable haemodynamics including abrupt chest pain cardiogenic shock, unstable blood pressure (systolic < 90mmHg), severe congestive heart failure or pulmonary edema
  • •Life-threatening diseases (life expectancy < 2 months)
  • •Tako Tsubo syndrome (TTS)
  • •Others who are inappropriate subject judged by clinician

研究组 & 干预措施

Study group

Experimental

All consecutive patients undergoing outine CT angiography and dynamic CT-myocardial perfusion imaging(MPI) will be potentially eligible for inclusion in the trial. Assessment of coronary stenosis severity using invasive fractional flow reserve (FFR) and the status of myocardial microcirculation perfusion including coronary flow reserve (CFR) and index of microvascular resistance (IMR) will be performed as part of invasive coronary angiography(CAG).

干预措施: CCTA, CT-MPI, DSA, FFR (Diagnostic Test)

结局指标

主要结局

sensitivity and specificity

时间窗: up to 12 months

The sensitivity and specificity of CT-IMR in the diagnosis of microcirculation dysfunction were studied.

次要结局

  • diagnostic(up to 12 months)

研究者

发起方
First People's Hospital of Hangzhou
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinyu Huang

professor

First People's Hospital of Hangzhou

研究点 (1)

Loading locations...

相似试验